Literature DB >> 18622266

Chromosome 17: association of a large inversion polymorphism with corticosteroid response in asthma.

Kelan G Tantisira1, Ross Lazarus, Augusto A Litonjua, Barbara Klanderman, Scott T Weiss.   

Abstract

A 900-kb inversion exists within a large region of conserved linkage disequilibrium (LD) on chromosome 17. CRHR1 is located within the inversion region and associated with inhaled corticosteroid response in asthma. We hypothesized that CRHR1 variants are in LD with the inversion, supporting a potential role for natural selection in the genetic response to corticosteroids. We genotyped six single nucleotide polymorphisms (SNPs) spanning chromosome 17: 40,410,565-42,372,240, including four SNPs defining inversion status. Similar allele frequencies and strong LD were noted between the inversion and a CRHR1 SNP previously associated with lung function response to inhaled corticosteroids. Each inversion-defining SNP was strongly associated with inhaled corticosteroid response in adult asthma (P values 0.002-0.005). The CRHR1 response to inhaled corticosteroids may thus be explained by natural selection resulting from inversion status or by long-range LD with another gene. Additional pharmacogenetic investigations into regions of chromosomal diversity, including copy number variation and inversions, are warranted.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18622266      PMCID: PMC3225071          DOI: 10.1097/FPC.0b013e3282fe6ebf

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  15 in total

1.  The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group.

Authors: 
Journal:  Control Clin Trials       Date:  1999-02

2.  Long-term effects of budesonide or nedocromil in children with asthma.

Authors:  Stanley Szefler; Scott Weiss; James Tonascia; N Franklin Adkinson; Bruce Bender; Reuben Cherniack; Michele Donithan; H William Kelly; Joseph Reisman; Gail G Shapiro; Alice L Sternberg; Robert Strunk; Virginia Taggart; Mark Van Natta; Robert Wise; Margaret Wu; Robert Zeiger
Journal:  N Engl J Med       Date:  2000-10-12       Impact factor: 91.245

3.  Impact of the CYP2D6 ultra-rapid metabolizer genotype on doxepin pharmacokinetics and serotonin in platelets.

Authors:  Julia Kirchheiner; Hanns-Benjamin Henckel; Leonora Franke; Ingolf Meineke; Mladen Tzvetkov; Ralf Uebelhack; Ivar Roots; Jürgen Brockmöller
Journal:  Pharmacogenet Genomics       Date:  2005-08       Impact factor: 2.089

4.  Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial.

Authors:  R F Lemanske; C A Sorkness; E A Mauger; S C Lazarus; H A Boushey; J V Fahy; J M Drazen; V M Chinchilli; T Craig; J E Fish; J G Ford; E Israel; M Kraft; R J Martin; S A Nachman; S P Peters; J D Spahn; S J Szefler
Journal:  JAMA       Date:  2001 May 23-30       Impact factor: 56.272

5.  A comparison of the clinical characteristics of children and adults with severe asthma.

Authors:  Henry A Jenkins; Reubin Cherniack; Stanley J Szefler; Ronina Covar; Erwin W Gelfand; Joseph D Spahn
Journal:  Chest       Date:  2003-10       Impact factor: 9.410

6.  Linkage disequilibrium and haplotype tagging polymorphisms in the Tau H1 haplotype.

Authors:  Sofia A Oliveira; William K Scott; Fengyu Zhang; Jeffrey M Stajich; Kenichiro Fujiwara; Michael Hauser; Burton L Scott; Margaret A Pericak-Vance; Jeffery M Vance; Eden R Martin
Journal:  Neurogenetics       Date:  2004-06-08       Impact factor: 2.660

7.  Chromosomal speciation and molecular divergence--accelerated evolution in rearranged chromosomes.

Authors:  Arcadi Navarro; Nick H Barton
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

8.  Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase.

Authors:  P M Holland; R D Abramson; R Watson; D H Gelfand
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

9.  Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids.

Authors:  Kelan G Tantisira; Stephen Lake; Eric S Silverman; Lyle J Palmer; Ross Lazarus; Edwin K Silverman; Stephen B Liggett; Erwin W Gelfand; Lanny J Rosenwasser; Brent Richter; Elliot Israel; Michael Wechsler; Stacey Gabriel; David Altshuler; Eric Lander; Jeffrey Drazen; Scott T Weiss
Journal:  Hum Mol Genet       Date:  2004-05-05       Impact factor: 6.150

10.  The structure of the tau haplotype in controls and in progressive supranuclear palsy.

Authors:  Alan M Pittman; Amanda J Myers; Jaime Duckworth; Leslie Bryden; Melissa Hanson; Patrick Abou-Sleiman; Nicholas W Wood; John Hardy; Andrew Lees; Rohan de Silva
Journal:  Hum Mol Genet       Date:  2004-04-28       Impact factor: 6.150

View more
  21 in total

Review 1.  Asthma Pharmacogenomics: 2015 Update.

Authors:  Joshua S Davis; Scott T Weiss; Kelan G Tantisira
Journal:  Curr Allergy Asthma Rep       Date:  2015-07       Impact factor: 4.806

2.  The effect of genomic inversions on estimation of population genetic parameters from SNP data.

Authors:  Nafisa-Katrin Seich Al Basatena; Clive J Hoggart; Lachlan J Coin; Paul F O'Reilly
Journal:  Genetics       Date:  2012-11-12       Impact factor: 4.562

3.  Pharmacogenetics of asthma controller treatment.

Authors:  E B Mougey; C Chen; K G Tantisira; K V Blake; S P Peters; R A Wise; S T Weiss; J J Lima
Journal:  Pharmacogenomics J       Date:  2012-02-28       Impact factor: 3.550

Review 4.  The pharmacogenetics and pharmacogenomics of asthma therapy.

Authors:  S M Tse; K Tantisira; S T Weiss
Journal:  Pharmacogenomics J       Date:  2011-10-11       Impact factor: 3.550

Review 5.  Asthma and Corticosteroid Responses in Childhood and Adult Asthma.

Authors:  Amira Ali Ramadan; Jonathan M Gaffin; Elliot Israel; Wanda Phipatanakul
Journal:  Clin Chest Med       Date:  2019-03       Impact factor: 2.878

6.  Association between ORMDL3, IL1RL1 and a deletion on chromosome 17q21 with asthma risk in Australia.

Authors:  Manuel A R Ferreira; Allan F McRae; Sarah E Medland; Dale R Nyholt; Scott D Gordon; Margaret J Wright; Anjali K Henders; Pamela A Madden; Peter M Visscher; Naomi R Wray; Andrew C Heath; Grant W Montgomery; David L Duffy; Nicholas G Martin
Journal:  Eur J Hum Genet       Date:  2010-12-08       Impact factor: 4.246

Review 7.  Pharmacogenetics of asthma.

Authors:  John J Lima; Kathryn V Blake; Kelan G Tantisira; Scott T Weiss
Journal:  Curr Opin Pulm Med       Date:  2009-01       Impact factor: 3.155

8.  H2 haplotype at chromosome 17q21.31 protects against childhood sexual abuse-associated risk for alcohol consumption and dependence.

Authors:  Elliot C Nelson; Arpana Agrawal; Michele L Pergadia; Jen C Wang; John B Whitfield; F Scott Saccone; Jason Kern; Julia D Grant; Andrew J Schrage; John P Rice; Grant W Montgomery; Andrew C Heath; Alison M Goate; Nicholas G Martin; Pamela A F Madden
Journal:  Addict Biol       Date:  2010-01       Impact factor: 4.280

Review 9.  Advances in adult asthma diagnosis and treatment and health outcomes, education, delivery, and quality in 2008.

Authors:  Andrea J Apter
Journal:  J Allergy Clin Immunol       Date:  2009-01       Impact factor: 10.793

Review 10.  Pharmacogenetics and interstitial lung disease.

Authors:  Justin M Oldham; Imre Noth; Fernando J Martinez
Journal:  Curr Opin Pulm Med       Date:  2016-09       Impact factor: 3.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.